Brief: Catalyst Pharma Says Angelini Pharma Deal Includes Termination Fee Of About $155.5 Mln

Catalyst Pharmaceuticals

07/05/2026 14:05

May 7 (Reuters) - Catalyst Pharmaceuticals Inc CPRX.O:

UPON TERMINATION OF  MERGER AGREEMENT, CO WILL BE REQUIRED TO PAY ANGELINI PHARMA TERMINATION FEE OF ABOUT $155.5 MILLION

Source text: [ID:n0001193125-26-210518]

Further company coverage: CPRX.O

 ((Reuters.Briefs@thomsonreuters.com;))